Indeed, several studies concerning the IDO1/Kyn/AhR metabolic axis argue that IFN-γ is needed only for initiation but not maintenance of tumour dormancy – some other factors have been involved in the consecutive IDO1 activity (24–26). This evidence concerns the gene AHR and neoplasm.